Risk Factors Of Ipsilateral Breast Tumor Recurrence In Triple-Negative Or Her2-Positive Breast Cancer Patients Who Achieved Pathological Complete Response After Neoadjuvant Chemotherapy.
JOURNAL OF CLINICAL ONCOLOGY(2020)
Abstract
e12599Background: To date, patients undergo breast surgery after neoadjvant chemotherapy (NAC) even though they achieve clinical complete response (cCR). The safety of omitting breast surgery for t...
MoreTranslated text
Key words
ipsilateral breast tumor recurrence,breast cancer,neoadjuvant chemotherapy,cancer patients,triple-negative
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined